Bumper Offer - Urjas oil Just @ Rs. 1
Xylo 4% Injection is a commercial drug that is prescribed in the form of Injection. It is primarily used for the treatment of Local Anesthesia. Other than this, Xylo 4% Injection has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Xylo 4% Injection is largely dependent on the individual's body weight, medical history, gender and age. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
Common side effects of Xylo 4% Injection include Skin redness. Besides the aforementioned side effects, there are other adverse effects of Xylo 4% Injection as well, which are listed below. These side effects of Xylo 4% Injection are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Xylo 4% Injection's effect is Mild during pregnancy and Mild for lactating mothers. In addition, Xylo 4% Injection's effects on the liver, heart and kidney are discussed below in the Xylo 4% Injection related warnings section.
Individuals suffering from medical conditions like Heart Failure, Liver Disease must refrain from the use of Xylo 4% Injection since this can cause severe adverse effects. The section on Xylo 4% Injection contraindications lists all such conditions.
Drug interactions for Xylo 4% Injection have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Xylo 4% Injection is considered not safe while driving, and is not addictive.
Xylo 4% Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 2 - 12 years (Child) |
|
| 13 - 18 years (Adolescent) |
|
Based on research, the following side effects have been observed when Xylo 4% Injection is used -
Severe
Moderate
Mild
Common
Is the use of Xylo 4% Injection safe for pregnant women?
Xylo has mild to no side effects in pregnant women.
Is the use of Xylo 4% Injection safe during breastfeeding?
Side effects of Xylo on breastfeeding women are very mild.
What is the effect of Xylo 4% Injection on the Kidneys?
Xylo may have mild side effects on the kidneys.
What is the effect of Xylo 4% Injection on the Liver?
Xylo is rarely harmful for the liver.
What is the effect of Xylo 4% Injection on the Heart?
Xylo has very mild side effects on the heart.
Xylo 4% Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Xylo 4% Injection unless your doctor advises you to do so -
Is this Xylo 4% Injection habit forming or addictive?
No, there is no any evidence that Xylo 4% Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Xylo 4% Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Xylo 4% Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Xylo 4% Injection is unable to treat or cure mental disorders.
Interaction between Food and Xylo 4% Injection
Eating certain foods may increase the time it takes Xylo 4% Injection to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Xylo 4% Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Xylo 4% Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xylocaine (lidocaine HCl)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 366
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 771-775